Global Poultry Liquid Vaccine 麻豆原创 Growth 2024-2030

Publication ID:

LPI11246922

Publication Date:

November 14, 2024

Pages:

143

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Poultry Liquid Vaccine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淧oultry Liquid Vaccine Industry Forecast鈥� looks at past sales and reviews total world Poultry Liquid Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected Poultry Liquid Vaccine sales for 2024 through 2030. With Poultry Liquid Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poultry Liquid Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Poultry Liquid Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poultry Liquid Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Poultry Liquid Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poultry Liquid Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poultry Liquid Vaccine.
United States market for Poultry Liquid Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Poultry Liquid Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Poultry Liquid Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Poultry Liquid Vaccine players cover Merck, Boehringer Ingelheim, Ceva, Zoetis, 痴补虫虫颈苍辞惫补庐, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Poultry Liquid Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Live
Attenuated
Killed
Segmentation by Application:
NDV
Marek ' s Disease
IBD
Infectious Bronchitis
Influenza
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Boehringer Ingelheim
Ceva
Zoetis
痴补虫虫颈苍辞惫补庐
Elanco
QYH Biotech Co., Ltd
Pulike
Phibro Animal Health Corporation
JinYu Biotechnology
Harbin Pharmaceutical Group
MEVAC
Venky's
Japfa Comfeed Indonesia
Nisseiken
Hile
Hester Biosciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Poultry Liquid Vaccine market?
What factors are driving Poultry Liquid Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Poultry Liquid Vaccine market opportunities vary by end market size?
How does Poultry Liquid Vaccine break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Poultry Liquid Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Poultry Liquid Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Poultry Liquid Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Poultry Liquid Vaccine Segment by Type
2.2.1 Live
2.2.2 Attenuated
2.2.3 Killed
2.3 Poultry Liquid Vaccine Sales by Type
2.3.1 Global Poultry Liquid Vaccine Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Poultry Liquid Vaccine Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Poultry Liquid Vaccine Sale Price by Type (2019-2024)
2.4 Poultry Liquid Vaccine Segment by Application
2.4.1 NDV
2.4.2 Marek ' s Disease
2.4.3 IBD
2.4.4 Infectious Bronchitis
2.4.5 Influenza
2.4.6 Others
2.5 Poultry Liquid Vaccine Sales by Application
2.5.1 Global Poultry Liquid Vaccine Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Poultry Liquid Vaccine Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Poultry Liquid Vaccine Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Poultry Liquid Vaccine Breakdown Data by Company
3.1.1 Global Poultry Liquid Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Poultry Liquid Vaccine Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Poultry Liquid Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Poultry Liquid Vaccine Revenue by Company (2019-2024)
3.2.2 Global Poultry Liquid Vaccine Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Poultry Liquid Vaccine Sale Price by Company
3.4 Key Manufacturers Poultry Liquid Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Poultry Liquid Vaccine Product Location Distribution
3.4.2 Players Poultry Liquid Vaccine Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Poultry Liquid Vaccine by Geographic Region
4.1 World Historic Poultry Liquid Vaccine 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Poultry Liquid Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Poultry Liquid Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Poultry Liquid Vaccine 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Poultry Liquid Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Poultry Liquid Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Poultry Liquid Vaccine Sales Growth
4.4 APAC Poultry Liquid Vaccine Sales Growth
4.5 Europe Poultry Liquid Vaccine Sales Growth
4.6 Middle East & Africa Poultry Liquid Vaccine Sales Growth
5 Americas
5.1 Americas Poultry Liquid Vaccine Sales by Country
5.1.1 Americas Poultry Liquid Vaccine Sales by Country (2019-2024)
5.1.2 Americas Poultry Liquid Vaccine Revenue by Country (2019-2024)
5.2 Americas Poultry Liquid Vaccine Sales by Type (2019-2024)
5.3 Americas Poultry Liquid Vaccine Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Poultry Liquid Vaccine Sales by Region
6.1.1 APAC Poultry Liquid Vaccine Sales by Region (2019-2024)
6.1.2 APAC Poultry Liquid Vaccine Revenue by Region (2019-2024)
6.2 APAC Poultry Liquid Vaccine Sales by Type (2019-2024)
6.3 APAC Poultry Liquid Vaccine Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Poultry Liquid Vaccine by Country
7.1.1 Europe Poultry Liquid Vaccine Sales by Country (2019-2024)
7.1.2 Europe Poultry Liquid Vaccine Revenue by Country (2019-2024)
7.2 Europe Poultry Liquid Vaccine Sales by Type (2019-2024)
7.3 Europe Poultry Liquid Vaccine Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Poultry Liquid Vaccine by Country
8.1.1 Middle East & Africa Poultry Liquid Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Poultry Liquid Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Poultry Liquid Vaccine Sales by Type (2019-2024)
8.3 Middle East & Africa Poultry Liquid Vaccine Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Poultry Liquid Vaccine
10.3 Manufacturing Process Analysis of Poultry Liquid Vaccine
10.4 Industry Chain Structure of Poultry Liquid Vaccine
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Poultry Liquid Vaccine Distributors
11.3 Poultry Liquid Vaccine Customer
12 World Forecast Review for Poultry Liquid Vaccine by Geographic Region
12.1 Global Poultry Liquid Vaccine 麻豆原创 Size Forecast by Region
12.1.1 Global Poultry Liquid Vaccine Forecast by Region (2025-2030)
12.1.2 Global Poultry Liquid Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Poultry Liquid Vaccine Forecast by Type (2025-2030)
12.7 Global Poultry Liquid Vaccine Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Poultry Liquid Vaccine Product Portfolios and Specifications
13.1.3 Merck Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Poultry Liquid Vaccine Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Ceva
13.3.1 Ceva Company Information
13.3.2 Ceva Poultry Liquid Vaccine Product Portfolios and Specifications
13.3.3 Ceva Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Ceva Main Business Overview
13.3.5 Ceva Latest Developments
13.4 Zoetis
13.4.1 Zoetis Company Information
13.4.2 Zoetis Poultry Liquid Vaccine Product Portfolios and Specifications
13.4.3 Zoetis Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Zoetis Main Business Overview
13.4.5 Zoetis Latest Developments
13.5 痴补虫虫颈苍辞惫补庐
13.5.1 痴补虫虫颈苍辞惫补庐 Company Information
13.5.2 痴补虫虫颈苍辞惫补庐 Poultry Liquid Vaccine Product Portfolios and Specifications
13.5.3 痴补虫虫颈苍辞惫补庐 Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 痴补虫虫颈苍辞惫补庐 Main Business Overview
13.5.5 痴补虫虫颈苍辞惫补庐 Latest Developments
13.6 Elanco
13.6.1 Elanco Company Information
13.6.2 Elanco Poultry Liquid Vaccine Product Portfolios and Specifications
13.6.3 Elanco Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Elanco Main Business Overview
13.6.5 Elanco Latest Developments
13.7 QYH Biotech Co., Ltd
13.7.1 QYH Biotech Co., Ltd Company Information
13.7.2 QYH Biotech Co., Ltd Poultry Liquid Vaccine Product Portfolios and Specifications
13.7.3 QYH Biotech Co., Ltd Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 QYH Biotech Co., Ltd Main Business Overview
13.7.5 QYH Biotech Co., Ltd Latest Developments
13.8 Pulike
13.8.1 Pulike Company Information
13.8.2 Pulike Poultry Liquid Vaccine Product Portfolios and Specifications
13.8.3 Pulike Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pulike Main Business Overview
13.8.5 Pulike Latest Developments
13.9 Phibro Animal Health Corporation
13.9.1 Phibro Animal Health Corporation Company Information
13.9.2 Phibro Animal Health Corporation Poultry Liquid Vaccine Product Portfolios and Specifications
13.9.3 Phibro Animal Health Corporation Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Phibro Animal Health Corporation Main Business Overview
13.9.5 Phibro Animal Health Corporation Latest Developments
13.10 JinYu Biotechnology
13.10.1 JinYu Biotechnology Company Information
13.10.2 JinYu Biotechnology Poultry Liquid Vaccine Product Portfolios and Specifications
13.10.3 JinYu Biotechnology Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 JinYu Biotechnology Main Business Overview
13.10.5 JinYu Biotechnology Latest Developments
13.11 Harbin Pharmaceutical Group
13.11.1 Harbin Pharmaceutical Group Company Information
13.11.2 Harbin Pharmaceutical Group Poultry Liquid Vaccine Product Portfolios and Specifications
13.11.3 Harbin Pharmaceutical Group Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Harbin Pharmaceutical Group Main Business Overview
13.11.5 Harbin Pharmaceutical Group Latest Developments
13.12 MEVAC
13.12.1 MEVAC Company Information
13.12.2 MEVAC Poultry Liquid Vaccine Product Portfolios and Specifications
13.12.3 MEVAC Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 MEVAC Main Business Overview
13.12.5 MEVAC Latest Developments
13.13 Venky's
13.13.1 Venky's Company Information
13.13.2 Venky's Poultry Liquid Vaccine Product Portfolios and Specifications
13.13.3 Venky's Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Venky's Main Business Overview
13.13.5 Venky's Latest Developments
13.14 Japfa Comfeed Indonesia
13.14.1 Japfa Comfeed Indonesia Company Information
13.14.2 Japfa Comfeed Indonesia Poultry Liquid Vaccine Product Portfolios and Specifications
13.14.3 Japfa Comfeed Indonesia Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Japfa Comfeed Indonesia Main Business Overview
13.14.5 Japfa Comfeed Indonesia Latest Developments
13.15 Nisseiken
13.15.1 Nisseiken Company Information
13.15.2 Nisseiken Poultry Liquid Vaccine Product Portfolios and Specifications
13.15.3 Nisseiken Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Nisseiken Main Business Overview
13.15.5 Nisseiken Latest Developments
13.16 Hile
13.16.1 Hile Company Information
13.16.2 Hile Poultry Liquid Vaccine Product Portfolios and Specifications
13.16.3 Hile Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Hile Main Business Overview
13.16.5 Hile Latest Developments
13.17 Hester Biosciences
13.17.1 Hester Biosciences Company Information
13.17.2 Hester Biosciences Poultry Liquid Vaccine Product Portfolios and Specifications
13.17.3 Hester Biosciences Poultry Liquid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Hester Biosciences Main Business Overview
13.17.5 Hester Biosciences Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.